Detalhe da pesquisa
1.
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies.
Int J Cancer
; 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38721724
2.
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10388): 1571-1583, 2023 05 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37116523
3.
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1.
Blood
; 140(24): 2594-2610, 2022 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35857899
4.
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive post-remission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 2024 Feb 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38385304
5.
Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases.
Acta Derm Venereol
; 104: adv13381, 2024 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38323498
6.
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Blood
; 137(22): 3093-3104, 2021 06 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33598693
7.
Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question.
Haematologica
; 108(2): 342-352, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36722404
8.
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.
Haematologica
; 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38058184
9.
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Haematologica
; 108(8): 2059-2066, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36815361
10.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35678031
11.
Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage.
Pharm Stat
; 22(2): 236-247, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36285348
12.
Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors.
Transfus Med Hemother
; 50(5): 396-402, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37899994
13.
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood
; 136(26): 3041-3050, 2020 12 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33367545
14.
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Blood
; 135(5): 371-380, 2020 01 30.
Artigo
Inglês
| MEDLINE | ID: mdl-31826241
15.
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin.
Haematologica
; 107(9): 2064-2071, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35142153
16.
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.
Haematologica
; 107(4): 836-843, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34348451
17.
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Br J Haematol
; 192(5): 832-842, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33529373
18.
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series.
Oncologist
; 26(1): 7-16, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32852072
19.
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
Blood
; 134(19): 1608-1618, 2019 11 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31554635
20.
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Blood
; 133(8): 840-851, 2019 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-30563875